Novel Treatment Regimen Results in Complete Viral Elimination for Immunocompromised Patients With B-Cell Lymphoma and COVID-19 Infection
The following is a summary of “Evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibody,” published in the...